Skip to main content
. 2022 Oct 15;36(11):1207–1216. doi: 10.1007/s40263-022-00956-8

Table 4.

Changes in chorea and motor scores

Change in UHDRS TMC score Change in UHDRS TMS
Change from baseline to week 8
 Rollover cohort − 4.4 (3.1) − 7.1 (7.3)
 Switch cohort − 2.1 (3.3) − 2.4 (8.7)
Change from week 8 to week 145a
 All subjects − 0.5 (5.2) 8.2 (11.9)

Values shown are mean (SD)

SD standard deviation, TMC total maximal chorea, TMS total motor score, UHDRS Unified Huntington’s Disease Rating Scale

aThe Rollover and Switch cohorts were analyzed separately from baseline through week 8. The two cohorts were combined for the analysis of changes from week 8 to week 145 (or the last visit on the study drug, if that occurred earlier)